Hematology

Filter

SGLT2 Inhibitors Linked to Higher Haemoglobin and Haematocrit

October 2026

A meta-analysis of 85 randomised clinical trials found that SGLT2 inhibitors were associated with modest increases in haemoglobin and haematocrit, alongside changes in erythropoietin and transferrin saturation.

SGLT2 Inhibitors Linked to Higher Haemoglobin and Haematocrit

A meta-analysis of 85 randomised clinical trials found that SGLT2 inhibitors were associated with modest increases in haemoglobin and haematocrit, alongside changes in erythropoietin and transferrin saturation.

pre-closure intraoperative fibrinogen

Pre-Closure Fibrinogen and Haemostasis in Spine Surgery

Pre-closure intraoperative fibrinogen has been associated with favourable early postoperative haemostasis in patients undergoing spinal deformity surgery.

hydroxyurea infection risk

Hydroxyurea Does Not Increase Infection Risk in Sickle Cell Anaemia

Hydroxyurea was not associated with increased infection risk in children with sickle cell anaemia, with rates declining through treatment phases.

Venetoclax Bridges Children With Relapsed Leukemia to Transplant

Venetoclax-based therapy enabled many children with relapsed acute leukaemia to proceed to stem cell transplantation.

Arterial Thromboembolism Risk Identified in Multiple Myeloma

A Myeloma-XI analysis identified clinical, tumour and inherited genetic factors associated with arterial thromboembolism risk in multiple myeloma.

Shwachman-Diamond syndrome haematopoietic cell transplantation HCT AML MDS bone marrow failure haematology

Earlier Transplant May Improve Shwachman-Diamond Outcomes

Earlier transplantation after high-risk features emerge may improve survival in Shwachman-Diamond syndrome.

a woman holding her nose

Transplant Immunosuppression Regimens Affect Sinonasal Disease

A multicentre study found associations between transplant immunosuppression regimens and rates of sinonasal disease, allergic rhinitis and acute invasive fungal sinusitis.

Supportive Anaemia Treatment May Maintain Ruxolitinib Dosing

Anaemia-supporting therapy may help patients with myelofibrosis maintain ruxolitinib dosing and clinical responses.

Loading posts...

1 2 3 … 55 Next »